Radiomolecular Theranostics With Fibroblast-Activation-Protein Inhibitors and Peptides

被引：5

作者：

Baum, Richard P. ^{[1
,9
]}

Novruzov, Emil ^{[2
]}

Zhao, Tianzhi ^{[3
,4
,5
]}

Greifenstein, Lukas ^{[1
]}

Jakobsson, Vivianne ^{[3
,4
,5
]}

Perrone, Elisabetta ^{[6
]}

Mishra, Aditi ^{[1
]}

Eismant, Aleksandr ^{[1
]}

Ghai, Kriti

Klein, Ortwin ^{[7
]}

Jaeschke, Bastian ^{[7
]}

Benz-Zils, Daniel ^{[1
]}

Cardinale, Jens ^{[2
]}

Mori, Yuriko ^{[2
]}

Giesel, Frederik L. ^{[2
,8
]}

Zhang, Jingjing ^{[3
,4
,5
]}

机构：

[1] DKD HELIOS Klin, Ctr Adv Radiomol Precis Oncol, Dept Nucl Med, Curanosticum Wiesbaden Frankfurt, Wiesbaden, Germany

[2] Heinrich Heine Univ, Univ Hosp Dusseldorf, Med Fac, Dept Nucl Med, Dusseldorf, Germany

[3] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Diagnost Radiol, Singapore, Singapore

[4] Natl Univ Singapore, Clin Imaging Res Ctr, Ctr Translat Med, Yong Loo Lin Sch Med, Singapore, Singapore

[5] Natl Univ Singapore, Yong Loo Lin Sch Med, Nanomed Translat Res Program, Singapore, Singapore

[6] Univ Cattolica Sacro Cuore, Inst Nucl Med, Dept Radiol & Hematol Sci, Rome, Italy

[7] Helios DKD Klin, Dept Oncol MVZ, Wiesbaden, Germany

[8] Osaka Univ, Inst Radiat Sci, Osaka, Japan

[9] DKD HELIOS Klin Wiesbaden, Ctr Adv Radiomol Precis Oncol, Aukammallee 33, D-65191 Wiesbaden, Germany

来源：

SEMINARS IN NUCLEAR MEDICINE | 2024年 / 54卷 / 04期

关键词：

TUMOR PROGRESSION; PHASE-I; CANCER; EXPERIENCE; THERAPY; PET/CT; EXPRESSION; TRACERS; BREAST;

D O I：

10.1053/j.semnuclmed.2024.05.010

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

The advancement of theranostics, which combines therapeutic and diagnostic capabilities in oncology, has significantly impacted cancer management. This review explores fibroblast activation protein (FAP) expression in the tumor microenvironment (TME) and its association with various malignancies, highlighting its potential as a theranostic marker for PET/CT imaging using FAP-targeted tracers and for FAP-targeted radiopharmaceutical therapy. We examine the development and clinical applications of FAP inhibitors (FAPIs) and peptides, providing insights into their diagnostic accuracy, initial therapeutic efficacy, and clinical impact across diverse cancer types, as well as the synthesis of novel FAP-targeted ligands. This review aims to showcase the promising outcomes and challenges in integrating FAPtargeted approaches into cancer management. Semin Nucl Med 54:537-556 (c) 2024 Published by Elsevier Inc.

引用

页码：537 / 556

页数：20

共 50 条

[31] Novel Fibroblast Activation Protein Inhibitor-Based Targeted Theranostics for Radioiodine-Refractory Differentiated Thyroid Cancer Patients: A Pilot Study
Ballal, Sanjana
Yadav, Madhav Prasad
Moon, Euy Sung
Roesch, Frank
Kumari, Samta
Agarwal, Shipra
Tripathi, Madhavi
Sahoo, Ranjit Kumar
Mangu, Bharadwaj Srinivas
Tupalli, Avinash
Bal, Chandrasekhar
THYROID, 2022, 32 (01) : 65 - 77
[32] The Latest Developments in Imaging of Fibroblast Activation Protein
Altmann, Annette
Haberkorn, Uwe
Siveke, Jens
JOURNAL OF NUCLEAR MEDICINE, 2021, 62 (02) : 160 - 167
[33] Fibroblast activation protein and chronic liver disease
Wang, Xin Maggie
Yao, Tsun-Wen
Nadvi, Naveed A.
Osborne, Brenna
McCaughan, Geoffrey W.
Gorrell, Mark D.
FRONTIERS IN BIOSCIENCE-LANDMARK, 2008, 13 : 3168 - 3180
[34] Development of fibroblast activation protein-α radiopharmaceuticals: Recent advances and perspectives
Yu, Ziyue
Jiang, Zeng
Cheng, Xuebo
Yuan, Leilei
Chen, Hualong
Ai, Lin
Wu, Zehui
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 277
[35] Cardiac Applications of Fibroblast Activation Protein Imaging
Diekmann, Johanna
Bengel, Frank M.
PET CLINICS, 2023, 18 (03) : 389 - 396
[36] Clinical results of fibroblast activation protein (FAP) specific PET for non-malignant indications: systematic review
Windisch, Paul
Zwahlen, Daniel R.
Giesel, Frederik L.
Scholz, Eberhard
Lugenbiel, Patrick
Debus, Juergen
Haberkorn, Uwe
Adeberg, Sebastian
EJNMMI RESEARCH, 2021, 11 (01)
[37] Preparation and Bioevaluation of 99mTc-Labeled FAP Inhibitors as Tumor Radiotracers to Target the Fibroblast Activation Protein
Ruan, Qing
Feng, Junhong
Jiang, Yuhao
Zhang, Xuran
Duan, Xiaojiang
Wang, Qianna
Yin, Guangxing
Xiao, Di
Zhang, Junbo
MOLECULAR PHARMACEUTICS, 2022, 19 (01) : 160 - 171
[38] Fibroblast activation protein imaging in atrial fibrillation: a proof-of-concept study
Li, Lina
Gao, Jie
Chen, Bi-Xi
Liu, Xingpeng
Shi, Liang
Wang, Yanjiang
Wang, Li
Wang, Yidan
Su, Pixiong
Yang, Min-Fu
Xie, Boqia
JOURNAL OF NUCLEAR CARDIOLOGY, 2023, 30 (06) : 2712 - 2720
[39] Current Status of Fibroblast Activation Protein Imaging in Gynecologic Malignancy and Breast Cancer
Dendl, Katharina
Koerber, Stefan A.
Watabe, Tadashi
Haberkorn, Uwe
Giesel, Frederik L.
PET CLINICS, 2023, 18 (03) : 345 - 351
[40] Expression of fibroblast activation protein in human pancreatic adenocarcinoma and its clinicopathological significance
Shi, Min
Yu, Dang-Hui
Chen, Ying
Zhao, Chen-Yan
Zhang, Jing
Liu, Qing-Hua
Ni, Can-Rong
Zhu, Ming-Hua
WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (08) : 840 - 846

← 1 2 3 4 5 →